EFAX - ETF AI Analysis
Top Page
SPDR MSCI EAFE Fossil Fuel Free ETF (EFAX)
EFAX, the SPDR MSCI EAFE Fossil Fuel Free ETF, has a solid overall rating driven mainly by high-quality international leaders like ASML, HSBC, Novartis, and AstraZeneca, which show strong financial performance, positive earnings outlooks, and generally supportive technical trends. Some holdings such as SAP and Commonwealth Bank of Australia face bearish technical signals, valuation concerns, or leverage and cash flow issues, which slightly weigh on the fund’s rating. The main risk factor is its concentration in large non-U.S. companies, where individual stock or regional challenges can have a noticeable impact on the ETF.
EFAX vs. SPDR S&P 500 ETF (SPY)
- AUM
- 487.16M
- Region
- Developed Markets
- Expense Ratio
- 0.20%
- Beta
- 0.77
- Issuer
- State Street
- Inception Date
- Oct 24, 2016
- Dividend Yield
- 3.21%
- Asset Class
- Equity
- Index Tracked
- MSCI EAFE ex Fossil Fuels
EFAX Summary
EFAX is an ETF that follows the MSCI EAFE ex Fossil Fuels index, giving you broad exposure to large and mid-sized companies in developed markets outside North America, while avoiding firms involved in fossil fuel extraction and production. It holds well-known names like Nestlé, Toyota, ASML, and HSBC, and spreads your money across many countries and sectors, which can help with diversification and long-term growth. A key risk is that its value can go up and down with global stock markets, and its fossil-fuel-free focus may perform differently from traditional international funds.
How much will it cost me?
This ETF has an expense ratio of 0.20%, which means you’ll pay about $2 per year for every $1,000 you invest. That’s slightly higher than the cheapest broad index ETFs, mainly because this fund tracks a specialized fossil-fuel-free index rather than a plain-vanilla market index.
What would affect this ETF?
EFAX could benefit if developed markets outside North America grow steadily, especially in sectors like financials, health care, and technology, and if global policies continue to favor low-carbon, fossil-fuel-free businesses, supporting its environmentally focused holdings such as ASML, Roche, and Nestlé. On the downside, slower economic growth in Europe and Asia, rising interest rates that pressure banks like HSBC and Mitsubishi UFJ, or regulatory changes that hurt large multinational companies could weigh on the ETF’s future performance.
EFAX Top 10 Holdings
EFAX leans heavily on a mix of European and Asian blue chips, with ASML acting as a key engine: despite some recent wobbling, its longer-term rise in semiconductors has been a major tailwind. Health care names like Roche and Novartis are steadily pulling their weight, giving the fund a defensive backbone. On the flip side, HSBC and Mitsubishi UFJ show more mixed, sometimes lagging momentum, leaving the financials as a bit of a wild card. With holdings spread across developed markets outside North America, EFAX offers global diversification with a fossil-fuel-free tilt.
| Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
 NL:ASML | ASML Holding NV | 3.33% | $16.14M | EUR 539.67B | 50.70% | 76Outperform |
 RHHVF | Roche Holding AG | ― | ― | ― | ― | 73Outperform |
 GB:HSBA | HSBC Holdings | 1.52% | $7.35M | GBP 218.81B | 19.37% | 80Outperform |
 CH:NOVN | Novartis AG | 1.50% | $7.26M | CHF 244.89B | 35.30% | 80Outperform |
 CH:NESN | Nestlé SA | 1.32% | $6.39M | CHF 217.87B | 9.36% | 71Outperform |
 AZN | AstraZeneca | ― | ― | ― | ― | 80Outperform |
 DE:SAP | SAP SE | 1.20% | $5.83M | EUR 246.65B | -6.46% | 66Neutral |
 JP:8306 | Mitsubishi UFJ Financial Group | 1.20% | $5.81M | JPY 38.80T | 48.45% | 76Outperform |
 DE:SIE | Siemens | 1.13% | $5.47M | EUR 202.50B | 7.55% | 74Outperform |
 AU:CBA | Commonwealth Bank of Australia | 1.00% | $4.84M | AUD 278.72B | -2.23% | 64Neutral |
EFAX Technical Analysis
Price Trends
Market Momentum
Evaluating momentum and price trends is crucial in ETF analysis to make informed investment decisions. For EFAX, the sentiment is Negative. The current price of 53.13 is below the 20-day moving average (MA) of 53.24, below the 50-day MA of 54.21, and above the 200-day MA of 53.02, indicating a neutral trend. The MACD of -0.24 indicates Negative momentum. The RSI at 45.70 is Neutral, neither overbought nor oversold. The STOCH value of 65.26 is Neutral, not indicating any strong overbought or oversold conditions. Overall, these indicators collectively point to a Negative sentiment for EFAX.
EFAX Peer Comparison
Comparison Results
| Name | Price | Price Target | AUM | Expense Ratio | Overall Rating |
|---|---|---|---|---|---|
| EFAX | $53.13 | $57.00(7.28% Upside) | $487.16M | 0.20% | 66Neutral |
 GSID | $74.21 | $89.78(20.98% Upside) | $995.77M | 0.20% | 66Neutral |
 JHMD | $44.21 | $52.82(19.47% Upside) | $997.62M | 0.39% | 64Neutral |
 NUDM | $39.18 | $53.76(37.22% Upside) | $893.74M | 0.27% | 64Neutral |
 IQDG | $42.13 | $51.20(21.52% Upside) | $685.18M | 0.42% | 67Neutral |
 DWM | $73.23 | $85.74(17.08% Upside) | $654.27M | 0.48% | 64Neutral |
Performance Comparison
| Show on chart | Ticker | Company Name | Price | Change | % Change |
|---|---|---|---|---|---|
| EFAX | SPDR MSCI EAFE Fossil Fuel Free ETF | 53.13 | 4.96 | 10.29% | |
| GSID | Goldman Sachs MarketBeta International Equity ETF | 74.21 | 8.59 | 13.10% | |
| JHMD | John Hancock Multifactor Developed International ETF | 44.21 | 5.18 | 13.28% | |
| NUDM | Nuveen ESG International Developed Markets Equity ETF | 39.18 | 3.87 | 10.96% | |
| IQDG | WisdomTree International Quality Dividend Growth Fund | 42.13 | 3.26 | 8.39% | |
| DWM | WisdomTree International Equity Fund | 73.23 | 8.74 | 13.55% |
This AI Analyst ETF Report is automatically generated by our AI systems using advanced algorithms and publicly available financial, technical, and market data. While the information provided aims to be accurate and insightful, it is intended for informational purposes only and should not be considered financial advice. Any content created by an AI (Artificial Intelligence) system may contain inaccuracies and/or contain errors. Investing in ETFs carries inherent risks, and past performance is not indicative of future results. This report does not account for your personal financial circumstances, objectives, or risk tolerance. Always conduct your own research or consult with a qualified financial advisor before making investment decisions. The analysis and recommendations provided are based on historical and current data and may not fully reflect future market conditions or unexpected developments. Neither the creators of this report nor its affiliated entities guarantee the accuracy, completeness, or reliability of the information presented. Use this report at your own discretion and risk.